Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.4B | 1.3B | 1.3B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 284M | 277.5M | 248.6M | 229.7M |
Operating income | 229.8M | 218.6M | 207M | 212.2M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 15M | 9.7M | 10.4M | 9.2M |
Other income expense | — | — | — | — |
Pretax income | 252.9M | 244.7M | 200.2M | 402.2M |
Tax provision | 60M | 45.5M | 78.8M | 82.7M |
Net income | 192.9M | 199.2M | 121.4M | 319.5M |
Basic EPS | — | 13.1 | 8.0 | 21.0 |
Diluted EPS | — | 13.1 | 8.0 | 21.0 |
Basic average shares | — | 15.2M | 15.2M | 15.2M |
Diluted average shares | — | 15.2M | 15.2M | 15.2M |
EBITDA | 397.6M | 360.2M | 305.7M | 338.8M |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |